Microarray-based comparative genomic hybridization of cancer targets reveals novel, recurrent genetic aberrations in the myelodysplastic syndromes

KA Kolquist, RA Schultz, A Furrow, TC Brown, JY Han… - Cancer Genetics, 2011 - Elsevier
The myelodysplastic syndromes (MDS) are a heterogeneous group of clonal disorders
characterized by ineffective hematopoiesis, cytopenias, and a risk of transformation to acute …
被引用次数：67 相关文章

Microarray-based comparative genomic hybridization of cancer targets reveals novel, recurrent genetic aberrations in the myelodysplastic syndromes

KA Kolquist, RA Schultz, A Furrow, TC Brown, JY Han… - Cancer Genetics, 2011 - infona.pl
The myelodysplastic syndromes (MDS) are a heterogeneous group of clonal disorders
characterized by ineffective hematopoiesis, cytopenias, and a risk of transformation to acute …

[引用][C] Microarray-based comparative genomic hybridization of cancer targets reveals novel, recurrent genetic aberrations in the myelodysplastic syndromes

KA Kolquist, RA Schultz, A Furrow, TC Brown, JY Han… - Cancer …, 2011 - cir.nii.ac.jp
Microarray-based comparative genomic hybridization of cancer targets reveals novel, recurrent
genetic aberrations in the myelodysplastic syndromes | CiNii Research CiNii 国立情報学研究所 …

Microarray-based comparative genomic hybridization of cancer targets reveals novel, recurrent genetic aberrations in the myelodysplastic syndromes

KA Kolquist, RA Schultz, A Furrow… - Cancer …, 2011 - cancergeneticsjournal.org
The myelodysplastic syndromes (MDS) are a heterogeneous group of clonal disorders
characterized by ineffective hematopoiesis, cytopenias, and a risk of transformation to acute …

Microarray-based comparative genomic hybridization of cancer targets reveals novel, recurrent genetic aberrations in the myelodysplastic syndromes

KA Kolquist, RA Schultz, A Furrow… - Cancer …, 2011 - pubmed.ncbi.nlm.nih.gov
The myelodysplastic syndromes (MDS) are a heterogeneous group of clonal disorders
characterized by ineffective hematopoiesis, cytopenias, and a risk of transformation to acute …

Microarray-based comparative genomic hybridization of cancer targets reveals novel, recurrent genetic aberrations in the myelodysplastic syndromes.

KA Kolquist, RA Schultz, A Furrow, TC Brown… - Cancer …, 2011 - europepmc.org
The myelodysplastic syndromes (MDS) are a heterogeneous group of clonal disorders
characterized by ineffective hematopoiesis, cytopenias, and a risk of transformation to acute …